Notably, for our lead variants rs2296312 (14q32.13-TCL1A) and rs8088824 (18q12.3-SETBP1), the alleles conferring increased DNMT3A-CH risk reduced hematological mCA risk (Supplementary Table 23). Here, SETBP1 is linked to cyclic hematopoiesis.